🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well a survivin peptide vaccine called SurVax...
Status
Not Yet Recruiting
Location
Rocky Mountain Regional VA Medical Center
Start Date
2026-10-01
Trial ID
NCT07169617
Diabetes mellitus is one of the most common metabolic disorders complicatin...
Status
Completed
Location
Department and Clinic of Neonatology, Jan Mikulicz-Radecki University Teaching Hospital, Wroclaw Medical University
Start Date
2019-12-13
Trial ID
NCT04937348
Systemic sclerosis (SSc) is the most severe of the systemic autoimmune dise...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT04986514
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
The GLUREDIA study investigates the counter-regulatory response (CRR) durin...
Status
Recruiting
Location
Clinique Universitaires Saint Luc
Start Date
2022-05-25
Trial ID
NCT06770621
In this study, the investigators aim to collect phenotypical and extensive ...
Status
Completed
Location
Cliniques Universitaires Saint-Luc
Start Date
2022-02-07
Trial ID
NCT05557539
Treatments Being Tested
The purpose of this research study is to learn more about lung cancer (NSCL...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2023-01-01
Trial ID
NCT05265429
Treatments Being Tested
The aims of this protocol are: to collect and store diseased and normal tis...
Status
Recruiting
Location
St. Jude Clinic at Huntsville Hospital for Women & Children
Start Date
2009-09-01
Trial ID
NCT01354002
The purpose of this study is to determine whether it is possible to predict...
Status
Terminated
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Start Date
2011-05
Trial ID
NCT01855061
Treatments Being Tested
Neurogenetic diseases (NGD) represent rare and hereditary forms of neurolog...
Status
Recruiting
Location
Chu de Bordeaux
Start Date
2024-07-18
Trial ID
NCT06048523
Treatments Being Tested